Dialysate sodium and sodium gradient in maintenance hemodialysis: a neglected sodium restriction approach?
- PMID: 21303968
- PMCID: PMC3108351
- DOI: 10.1093/ndt/gfq807
Dialysate sodium and sodium gradient in maintenance hemodialysis: a neglected sodium restriction approach?
Abstract
Background: A higher sodium gradient (dialysate sodium minus pre-dialysis plasma sodium) during hemodialysis (HD) has been associated with sodium loading; however, its role is not well studied. We hypothesized that a sodium dialysate prescription resulting in a higher sodium gradient is associated with increases in interdialytic weight gain (IDWG), blood pressure (BP) and thirst.
Methods: We conducted a cross-sectional study on 1084 clinically stable patients on HD. A descriptive analysis of the sodium prescription was performed and clinical associations with sodium gradient were analyzed.
Results: The dialysate sodium prescription varied widely across dialysis facilities, ranging from 136 to 149 mEq/L, with a median of 140 mEq/L. The mean pre-HD plasma sodium was 136.7 ± 2.9 mEq/L, resulting in the majority of subjects (n = 904, 83%) being dialyzed against a positive sodium gradient, while the mean sodium gradient was 4.6 ± 4.4 mEq/L. After HD, the plasma sodium increased in nearly all patients (91%), reaching a mean post-HD plasma sodium of 141.3 ± 2.5 mEq/L. We found a direct correlation between IDWG and sodium gradient (r = 0.21, P < 0.0001). After adjustment for confounders and clustering by facilities, the sodium gradient was independently associated with IDWG (70 g/mEq/L, P < 0.0001). There were no significant associations among sodium gradient and BP, whether measured as pre-HD systolic (r = -0.02), diastolic (r = -0.06) or mean arterial pressure (r = -0.04). Post-HD thirst was directly correlated with sodium gradient (r = 0.11, P = 0.02).
Conclusion: Sodium gradient is associated with statistically significant and clinically meaningful differences in IDWG in stable patients on HD.
Figures




Comment in
-
Do not forget to individualize dialysate sodium prescription.Nephrol Dial Transplant. 2011 Apr;26(4):1126-8. doi: 10.1093/ndt/gfr073. Epub 2011 Mar 3. Nephrol Dial Transplant. 2011. PMID: 21372263 No abstract available.
Similar articles
-
Clinical consequences of an individualized dialysate sodium prescription in hemodialysis patients.Kidney Int. 2004 Sep;66(3):1232-8. doi: 10.1111/j.1523-1755.2004.00876.x. Kidney Int. 2004. PMID: 15327422 Clinical Trial.
-
Increasing the dialysate sodium concentration based on serum sodium concentrations exacerbates weight gain and thirst in hemodialysis patients.Tohoku J Exp Med. 2013 Jun;230(2):117-21. doi: 10.1620/tjem.230.117. Tohoku J Exp Med. 2013. PMID: 23782720
-
Role of dialysis sodium gradient on intradialytic hypertension: an observational study.Am J Nephrol. 2013;38(5):413-9. doi: 10.1159/000355974. Epub 2013 Nov 5. Am J Nephrol. 2013. PMID: 24216674
-
Sodium balance in maintenance hemodialysis.Semin Dial. 2010 Nov-Dec;23(6):549-55. doi: 10.1111/j.1525-139X.2010.00794.x. Semin Dial. 2010. PMID: 21175831 Review.
-
Dialysate Sodium: Rationale for Evolution over Time.Semin Dial. 2017 Mar;30(2):99-111. doi: 10.1111/sdi.12570. Epub 2017 Jan 8. Semin Dial. 2017. PMID: 28066913 Free PMC article. Review.
Cited by
-
Low serum sodium is associated with protein energy wasting and increased interdialytic weight gain in haemodialysis patients.Clin Kidney J. 2014 Apr;7(2):156-60. doi: 10.1093/ckj/sft170. Epub 2014 Jan 20. Clin Kidney J. 2014. PMID: 25852864 Free PMC article.
-
Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass.BMC Nephrol. 2013 Jul 15;14:149. doi: 10.1186/1471-2369-14-149. BMC Nephrol. 2013. PMID: 23855560 Free PMC article. Clinical Trial.
-
Volume overload in hemodialysis: diagnosis, cardiovascular consequences, and management.Nephrol Dial Transplant. 2021 Dec 2;36(12):2182-2193. doi: 10.1093/ndt/gfaa182. Nephrol Dial Transplant. 2021. PMID: 33184659 Free PMC article. Review.
-
Outcomes after the long interdialytic break: implications for the dialytic prescription.Semin Dial. 2012 Jan-Feb;25(1):1-8. doi: 10.1111/j.1525-139X.2011.01015.x. Semin Dial. 2012. PMID: 22273522 Free PMC article.
-
Changes in serum sodium concentration during hemodialysis is a predictor of mortality and cardio-cerebrovascular event.Ren Fail. 2024 Dec;46(1):2338483. doi: 10.1080/0886022X.2024.2338483. Epub 2024 Apr 11. Ren Fail. 2024. PMID: 38604948 Free PMC article.
References
-
- Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(5 Suppl. 3):S112–S119. - PubMed
-
- Horl MP, Horl WH. Hemodialysis-associated hypertension: pathophysiology and therapy. Am J Kidney Dis. 2002;39:227–244. - PubMed
-
- Agarwal R, Nissenson AR, Batlle D, et al. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med. 2003;115:291–297. - PubMed
-
- Foley RN, Herzog CA, Collins AJ. Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study. Kidney Int. 2002;62:1784–1790. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical